PDS Biotechnology Corp Sustainability Reports
A clinical-stage biopharmaceutical company focused on developing a pipeline of multifunctional cancer immunotherapies and infectious disease vaccines based on its proprietary Versamune and Infectimune technology platforms.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 5493002KU8ACFTSMC935
FIGI: BBG004NCDKL7
4 reports from 2022 to 2025
